Skip to main content

About your Search

Search Results 0 to 16 of about 17
. for four years running now home depot in the united states, negative same store sales. no surprise, right? with the housing crisis. here in mexico, double-digit same store sales increases nearly continuously. how is that possible? we're going to explain. (announcer) at the end of a year, about 95% of smokers who try to quit cold turkey will be unsuccessful. if you haven't been able to quit smoking, you haven't failed, maybe your method of quitting has. but you can do it. you may just need the right tools. clinical guidelines recommend treatment and support to improve your chances of quitting smoking. why not get all the help you can? make a plan, get support, and talk to your doctor about prescription treatment options that can help you quit smoking. and to find out more, go to his is onstar reporting a stolen blue chevy tahoe, south on i-75, near exit 5. we're on it. onstar, we may have that tahoe. ok, i'll flash the lights. we got it. it's in the clear. i'm sending a signal to cut the power. we got him. mr. ross, the police have recovered your tahoe. >>> welcome back
. they beat, too. china's strength here, but generally weakness in the united states. boeing is down 1%. 2010 guidance disappointed the street overall. here is toyota which is going to be very busy this morning down 7% right now. trader scott, how we looking at the nasdaq? >> thanks so much. many of the big cap technology stocks looking positive in the premarket. apple the big story unveiling the tablet perhaps the worst kept secret in all of technology. nonetheless the shares are modestly higher ahead of that. amazon is up about 1%. a couple upgrades today. price target going from jani capital up from 1.60 to 2.35. yahoo up as well as wrulresultsn line. it sees positive revenue growth in the first quarter, the first time in six quarters yahoo achieves that. gilead is higher by 5% after better than expected results. united airlines on better than expected results as well. its parent company uaua is up about 3.5%. let's go to sharon at the nymex. >> oil prices are basically flat nearing the $75 mark as we wait for the energy department data on weekly petroleum supplies. the amer
and we're still trying to convince the white house as well that the united states sits on more natural gas energy than saudi arabia sits on oil. in fact the relationship is about 2 to 1, yet our fuel is much cheaper and cleaner as well. >> aubrey mcclendon, we appreciate it. >>> and p & g, the maker of tide detergent, we have this discussion about the scent of tide, and how a lot of people believe it is -- it is a special scent, and people pay a premium, because it is -- >> really? >> yes. >> i didn't know that, but then i don't spend a lot of time in the laundry room. >> our viewers e-mail in, and some say they know, and some port you to not doing laundry and others pick on you, and bring it on, everybody. >> i should do laundly just for defensive purposes so my clothes don't get sharunk. tlb ghosts of socks living in high house. >> i saw a story that said americans use way too much detergent, and their dingy and foul because we use too much. maybe they should stop selling that concentrated stuff. >> here are the dow supposed to be winners, jpmorgan chase flipped on us. now bank of am
their exposure to government bonds in britain and the united states, two of the most indebted countries. obviously coming on the heels of what was a terrible year. >> so they're continuing to can cut back. >> it sounds like it though of course treasuries were one of the weakest areas. >> all right. we're also getting a cold snap across much of the nation. that is impacting everything from oil to orange juice plus key data ahead. ism manufacturing and construction spending at 10:00 a.m. eastern time. both of course could move the markets. lets hit those markets now. we start with bob pisani at the big board. >> reporter: happy new year, everybody. a nice start to the year. highs of the day, futures up about eight points. european stocks up. oil is over $80. chinese manufacturing numbers are particularly strong here. let's talk about some companies. novartis says it is going to exercise an option to acquire a stake in the big eye care manufacturer. they already own 25%. once that deal is done looks like they'll bid for the remaining 23% of alcon. goldman sachs is raising price targets on
institutions, 35 of them domestic based institutions within the united states and it would raise about $90 billion, which is the amount of money that the administration believes t.a.r.p. will ultimately cost the american taxpayer once they've gotten all the repayments back that they're going to get. now, the banks don't like it. they've been criticizing the proposal and complaining about it but the head of the congressional oversight panel was on "squawk box" this morning and says she thinks it makes sense. >> if you're betting on this guarantee in effect from the government why shouldn't you pay for it through higher taxes or more regulation? but we really need to beef up. at the end of the day it's going to be about a credible liquidation system, a credible way to say in bankruptcy, if you make bad enough decisions, you end up in a place where your shareholders are wiped out, your top management is fired. >> and, mark and erin, i think in this season of very high profits on wall street, very high bonuses on wall street, the administration thinks this is a fight they welcome taking on and
population in all of the countries of the world. >> but the united states is far and away your largest market at the moment. so let's talk about the potential impact of health care reform here in the states. in a research note initiating coverage of your stock this week, by the way, with a buy rating, david maris pointed out you are in a business, these are his words, that has brutally low margins. so will you be able to make up in volume what you're already losing with super low prices? >> absolutely. i do believe that the additional 31 million potential customers for generic products are part of what we believe will increase our value because i believe that the volume is going to outpace the pricing pressure. in addition to that we also have a very nice blend making our profitability higher. >> i think a lot of people don't realize you make brand name drugs as well including a blockbuster by the way. yesterday you also said that the consolidation wave and the generic drug industry you think is going to continue and intensify. those are your words. on the other hand your north american ceo t
? >> look, your entire financial system, all the big players, six major banks in the united states their total balance sheet is over 60% of u.s.gdp. it got bigger during the crisis. all of the big guys are out there looking to take risks. so would you. so would i if we felt we were immune. if we had a get out of jail free card. wouldn't you take a lot of risks? of course. where? well, could be commodities. could be crazy things in the united states. i think though mostly it's going to be where everyone is sure the prices can only go up and that's china and other emerging markets. >> oh, crisis in china would be a pretty terrifying thing. simon, what is your image of what a crisis in china would be right now? >> that is a great question. china is obviously so hard to read, so many mirrors behind birrors but we've been more after japan type scenario. japan of course had the big massive runup in real estate. everyone in 1989 was convinced japan was going to be number one. >> right. >> we've been hearing a lot about china as number one and then a massive crash. you have a lot of saving
of product alone. >> mike, you know, teva is the largest pharmaceutical company in the united states when measured by prescriptions. we believe it's necessary for us to step up and lead the way. i think it's also, though, very -- it's a part of tev a's heritage that we are a company that hs given and continues to give. we believe in social responsibility. >> is that part of it being an israeli-based company. >> yes. that's part of our tear taj. >> obviously the people of haiti will hopefully gain access to much needed medicines through your donation. but what is the potential side benefit for teva, especially at a time when the pharmaceutical industry has taken such a huge hit to its image and a battering in the current health care reform debate? or does that not even enter into the equation? >> i think in the case of haiti, that really doesn't enter into our discussions. i think it is important for generic companies as well to be recognized for the good that we do. because all of the generic companies that we know do many good things. and so we're appreciative of everyone who can give in
the markets are moving. >> let's start with the adr that trades in the united states. we'll see reaction in about 25 minutes. heineken buying the beer assets. that will give them control of several companies. let's move on to the mexican market as well. there you can see femsa. the country of mexico, certainly the mexican markets will be rocked by the news that one of the leading industrialists there died in a helicopter crash due to fog along with two family members. a lot of real estate interests, a lot of also involved very much in tech. let's move on to the mexican market so we can show you that. whether or not it's definitely going to be affected by the death, not clear, but that market was closed to all-time highs all of last week. let's move on to argentina which continues with its constitutional crisis about whether or not the central government can seize $6.5 billion worth of money from the central bank. oh, mark. typical story we see all too often in latin america. back to you. >> we're not going to cry for argentina. all right. alan valdez joins us this morning. >> good mornin
very low for risk premium on the east coast of the united states. that year after four hurricanes, everyone's nerves were such rates went up spectacularly. they're lower again. is the risk of four hurricanes any different any of those times? >> mr. blankfein, having sat on the board of the california earthquake authority acts of god will exempt. these are acts of men and women. >> i'm just saying -- >> these are controllable. >> i agree. i sit here and read testimony to the effect of reducing our balance sheet, raising capital, clearly we are much less leveraged now. consequently i wish we were much less leveraged then even though we were much lower leverage than others and we had cash on our balance sheet and we did better under those circumstances. but if you're asking me would i do something differently? knowing what i know now? with respect to that capitalization? how could you not? of course. >> but liz wanted to put in context level of risk and the level of assistance. because this is something i think no one would want repeated again. let's do this then and move to question
and lower. yesterday at this time we were looking at 84. temperatures moderating here in the united states. we have a firmer dollar. we have china -- concerns about china. calm down, may be an overheating economy. that's what we're looking at. i also want to touch on narm gas. last week pretty firm sell-off. we have better pricing rights today. again, temperatures are looking at moderating at the enof the week here. the united states is much warmer here by the banks of the hudson here so that definitely bearish for natural gas despite the recent movements in the last few minutes. gold, silver, copper. gold dealing with the firmer dollar. copper again, china concerns they will temper. hiking rates a little bit and now trying to sort of deal with their overheating economy, if it is in fact overheating. let's go to rick in chicago. >> thank you, schachtman. thanks. we have a one-month bill, $10 billion and up to 3.6 and four-year $40 billion notes at 1:00 eastern. $76 billion in total. on a day you have that much supply, interest rates are actually moving lower. much of it, well, trade defici
between two very different parties. on the micro perspective here in the united states we're already forward thinking looking into the next term and how that's going to play into performance. i think there is a big correlation here between politically how some of these scenarios get put into the market and the other is how the markets proceed in these. a good colleague and friend has mentioned to me that he's very concerned about rates and how that plays into the equity markets and i would not disparage that only because there is the premise that if you start taking up rates on a percentage basis over 25% to 30% that that isn't positive for equities, which kind of gives me a window here of where we think stocks can trade at least for the first quarter. it's not just a correlation of how we think the job number will improve month over month or year to year. >> right. >> but at the same time all of a sudden you get these optimistic views of where the market can be, a forward thinking index in equities and all of a sudden you start reaching some ceilings. for me in the s&p i have refere
will immediately move out of the united states the minute congress gets ahold of monetary policy. and what you see, and i would applaud jim for diving into the numbers, what you see is that there is a clear skew between congressmen and senators up for re-election and those that are not in terms of how they would vote. in effect what you're already seeing is congress playing games with monetary policy. >> what happens, though, everyone takes all this, if he goes away the market is going to drop sharply. tan appears that maybe there is something to be said for that because there will be uncertainty about who is really in charge t could take a while for that to be determined. there is something to be said isn't there for the fact that we heard this argument last year about timothy geithner had to be approved. don't focus on the tax issue. he's the only guy who can do the job. and maybe people justifiably now say we don't want to hear this only guy can do the job argument again. >> i don't think he is the only guy that can do the job but i think you raise something very important which is an argument
. >> good afternoon, mike. >> when will you launch this drug in the united states? is your sales force ready to hit the ground running? and which doctors will they be targeting? >> our sales force has been ready for months now. this approval process took somewhat longer than we anticipated. so we'll be launching within weeks. we will start out hitting the key opinion leaders, specialists and then broaden out gradually to include all gps in the u.s. >> mr. sorensen, which type 2 diabetics can go on victorza? can they be on other diabetes drugs at the same time or do they have to go off them and take it all by itself? >> vivtorza is a second line treatment for individual 2 diabetes that cannot control blood sugar which is on the most commonly used drug. this means that victoza can replace some of the other second line drugs that are currently being used in the u.s. it is an injectable but very powerful blood sugar-lowering drug with a lot of other benefits. >> mr. sorensen, why are you pricing it in line though with a similar twice a day drug called byetta from eli lilly a? >> we have made an
. just think about the infrastructure buildup going on globally both with china, india, the united states. part of the stimulus plan. we're going to need a lot of industrial metals. >> do we really need another etf? >> i think we do, mark. only in that you need a retail investor to be able to buy something where he doesn't have exposure to the futures market. >> is this the only one? >> no, this is the second. we're going -- this is the only one in the industrial metals, absolutely. >> industrial metals that doesn't require future exposure. >> absolutely. this is a very safe investment. these companies will profit as we industrialize. china and brazil and india and -- yeah, i think it's a very important market. you ask that question all the time. >> i do. >> i like that question. it makes sense. >> let's face it, we're up to our cheeks in etfs now. >> 28% on the new york stock exchange is etf trading. >> is it? okay. now, so people should not expect this to correlate precisely with the industrial metals prices or the crb? >> that's exactly correct. >> you bought the equity, not the metal?
united states and a strong global economy. there's a strong financial system. and i'm not really sure splitting up the institutions in the way it's been envisioned would achieve that. >> have you benefited from all of the beating up on the larger firms? i mean are you getting business that would have gone there otherwise because of the independent nature of your firm? >> i think it's sort of an "and also" answer. i think as a result of what's happened in the financial markets the clients seem to want to reach out more toward firms that are independent. but we don't see ourselves as supplementing or replacing rather the large firms. we see it as a complement to the services provided by the large firms. because we're completely independent. we don't have a sales and trading business. we don't have the private equity business. and our whole focus is a client one. >> what does the pipeline look like for m & a real quick? >> it's quite good actually. that is really related to the confidence restored to the system though as i said before relative to a year ago it's better but still stressed
the dollar menu stuff? >> in the united states, tough is definitely difficult right now for the industry. the industry is probably negative three type same store sales or a little bit worse. these giles diduys did a plus o december which is an admirable number. we have a feeling traffic was better than that. the good news for mcdonald's is the margins on the company stores are holding up very well because food costs are going down. they're printing pretty good earnings, a little help from currency, and the european same store sales are holding up. they're looking a heck of a lot better than their competition right now. the average fast food chain away from mcdonald's in december, we think, did mid to high single digit negative same store sales. >> wow. what about their new -- there is something i saw advertised like sirloin steak bites or something like that. are the new products doing well? are you glad when they roll them out or not because there is more cost associated with it? >> well, it's tough to do new these days. the consumer doesn't want to try new. so what you've often seen is
Search Results 0 to 16 of about 17

Terms of Use (31 Dec 2014)